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Abstract 
To study the influence of the conformation of polypeptidic macromolecules on the generation of T-cell epitopes, sequential polypeptides with an 
octamer repeat unit were designed and synthesized. They adopt mainly unordered and a-helical conformations. Among these polypeptides, those 
containing proline are fully or partly unordered, and are more effective at inducing T-cell proliferation than a proline-free very stable a-helical 
polypeptide. This extremely stable a-helical conformation, probably stabilized by aggregation, would enhance its stability against proteolytic 
processing. 
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1. Introduction 
Short synthetic peptide immunogens are able to elicit 
a strong immune response only when attached to a car- 
rier protein [ 11. Previous studies have demonstrated that 
the induction of antibody responses against an haptenic 
determinant is mediated through cognate interaction be- 
tween hapten-specific B cells and carrier-specific helper 
T-cells [2]. To enlist T-cell help most short synthetic 
peptides have, therefore, to be conjugated to a larger 
protein carrier providing the necessary T-cell epitopes. 
T-cell epitope peptides are bound to the class II major 
histocompatibility molecule (MHC) in an extended con- 
formation [3]. However, relatively little is known about 
the requirements that must be satisfied by a carrier for 
immunization before processing and binding to a class 
II MHC molecule. Macromolecular polypeptides offer a 
unique system to study such a question. Suitable models 
simulating proteins have been studied as part of the anal- 
ysis of the immune response [4]. The multichain 
branched polypeptide poly-L-lysine-poly-m-alanine- 
poly-(tyrosine, glutamic acid) has been extensively stud- 
ied [5]. Based on this polypeptide, Hudecz and Szekerke 
[6] and Rajnaviilgy et al. [7] developed a class of synthetic 
branched polypeptides and studied the relationships be- 
tween their chemical structure and their carrier potency 
at the humoral level. To design a macromolecular carrier 
on a rational basis, it was interesting to investigate the 
influence of the conformation of the polypeptide macro- 
molecule on the generation of T-cell epitopes. 
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In this paper, we describe studies at the T-cellular level 
with sequential polypeptides in different conformations 
depending upon the absence or the presence of proline 
in the 8 residue repeating units. Their T-cell epitope ac- 
tivity was estimated by proliferation assays. Circular di- 
chroism (CD) spectroscopy was used to determine their 
conformation. 
2. Materials and methods 
2.1. Synthesis of‘H(Leu-Lys-Glu-Leu-Leu-Giu-Lys-Leu),OH: (Po)3 
(Po)3 was synthesized by the classical solid-phase method described 
by Merrifield [8] using the t-butyloxycarbonyl strategy and a PAM resin 
as solid support. The side chains of glutamic acid and lysine were 
protected by, respectively, cyclohexyl and 2-chlorobenzyloxycarbonyl 
groups. The peptide was deprotected and cleaved from the resin by 
liquid hydrogen fluoride [9], extracted with an aqueous acetic acid 
solution and lyophilized. The crude material was purified by gel-perme- 
ation on Sephadex G50 with 0.1 M acetic acid as eluent. Molecular 
weight was verified by mass spectrometry and agreed with the expected 
value, [M + HI’: 2919.6 (expected), 2918.1 (found). 
2.2. Poiypeptide synthesis 
The polydisperse polyoctapeptides were obtained by polycondensd- 
tion of the corresponding repeat unit. The octapeptides were synthe- 
sized by classical solution synthesis. Side chains of lysine and glutamic 
acid were protected by benzyloxycarbonyl and benzyl groups, respec- 
tively. These protecting groups were compatible with the o-nitrophen- 
ylsulphenyl group used for a-amino group protection. The C-terminal 
amino acid was protected in the form of the p-nitrophenyl ester which 
acts as the activating group during the polycondensation step according 
to the Goodman-Stueben [lo] ‘backing-off procedure. The peptide 
chain was elongated by DCCI couplings leading to the activated deriv- 
ative of the repeat unit. After each coupling step, the peptide was 
checked for purity by thin-layer chromatography using Merck pre- 
coated 60F 254 plates (silica gel). 
Polycondensation of the three protected octapeptide p-nitrophenyl 
esters was carried out by adding TEA to a very concentrated DMF 
solution (0.7 M of monomer) and in the presence of a stoichiometric 
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amount of I-hydroxybenzotriazole (HOBt) to reduce racemization. 
Lysyl and glutamyl protecting groups were cleaved by hydrobromic 
acid in trifluoroacetic acid. The crude polymers were dialyzed against 
0.01 N hydrochloric acid and water, and finally freeze-dried. The aver- 
age molecular weights were estimated by viscometry in TFA [l 11. 
2.3. Conformational and aggregation studies 
CD spectra were recorded between 190 and 300 nm on a Jobin-Yvon 
Mark IV dichrograph. The conditions used for each polypeptide are 
indicated in the legend of the figures. Ellipticities [0] are given per mean 
residue, in degree cm*/dmol. 
Osmometric molecular weight determinations were carried out using 
a Hewlett-Packard membrane osmometer equipped with a Spectrapor 
3 membrane (c.o. 3,500 Da) from Spectrum. 
2.4. Assay for prohferative responses of antigen-speciJic T cells 
Balb/c mice were injected in the hind footpads with 50 pg polypep- 
tide, dissolved in 25 ~1 0.9% NaCI, emulsified in 25 ~1 CFA. 10 days 
later, draining pophteal and/or inguinal ymph nodes were removed and 
a single cell suspension of T-cells prepared in RPM1 1640 (Gibco) 
containing 2 mM L-glutamine, antibiotics, 5 10m5 M 2_mercaptoetha- 
no1 and 10% foetal calf serum. T-cells were cultured in 0.2 ml at a final 
concentration of 2.5 IO6 cells in 96-well plates with or without antigen. 
After 4 days of culture (37°C 7.5% CO,) the cells were pulsed for 
18 h with [‘Hlthymidine and then collected on glass fiber filters with a 
Mash cell harvester. Incorporated radioactivity was determined by 
liquid scintillation counting. Results were expressed as the difference 
between cpm with and without antigen &pm). Standard deviation of 
quadruplicate cultures were about 10% of the mean. 
3. Results 
3.1. Choice of sequences 
The linear polymers were designed so as to adopt 
mainly unordered and a-helical conformations, with a 
sequence repeat unit of 8 amino acids in length. Barbier 
et al. [12] have shown that a strict alternation of hydro- 
philic (Lys-Lys) and hydrophobic (Leu-Leu) doublets 
induces, as a rule, the formation of an a-helix. Recently, 
we (unpublished results) and others [13] showed that 
polymers with predominant cationic groups could be 
toxic, while compounds with a balanced charge distribu- 
tion are not. Therefore, glutamyl residues were intro- 
duced to counterbalance the positive charges of the lysyl 
side chains. To obtain a stable a-helix, we chose to alter- 
nate Lys-Glu and Glu-Lys hydrophilic doublets to gen- 
erate i,i + 4 salt bridges between Glu and Lys side chains, 
which are known to have a stabilizing effect on the 
a-helical structure [14]. Thus, the repeat unit of 8 amino 
acids (P,,: LKELLEKL) was chosen. To break the 
a-helical conformation, one leucyl residue was replaced 
by an a-helix breaking prolyl residue [ 15,161 every 4 (P,: 
PKELPEKL) and every 8 (P,: LKELPEKL) amino 
acids, to obtain a polypeptide with a partial a-helical 
Table 1 
Sequences of polyoctapeptides 
Mol. weight (Da) 
(P& (Pro-Lys-Glu-Leu-Pro-Glu-Lys-Leu)n 16,800 
(P& (Leu-Lys-Glu-Leu-Pro-Glu-Lys-Leu)n 18,400 
(P& (Leu-Lys-Glu-Leu-Leu-Glu-Lys-Leu)n 12,120 
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Fig. I. Circular dichroism spectra of (P&n at a concentration of 0.1 
mg/ml in 0.001 N HCI, pH 3 (0.1 cm cell), and of (PJn and (P,)n at a 
concentration of 2 mg/ml in 0.1 M phosphate buffer, pH 7.1 (0.01 cm 
cell). 
conformation. The three octapeptidic repeat units were 
synthesized and polymerized to obtain macromolecules 
of molecular weight > 10,000 Da collated in Table 1. 
3.2. Conformation and aggregation studies 
As expected, (P&r is a-helical, as evidenced by CD 
spectroscopy (Fig. 1). Owing to its rather weak solubility 
in water, spectra were recorded at low concentrations. 
Ellipticity values corresponded to a nearly fully a-helical 
structure (found 8,,, = -30,000, typically -33,000). The 
stability of the helical structure was investigated by var- 
ying several parameters. It appeared that pH (from 3 to 
7.4), ionic strength (from pure water to 0.24 M NaF or 
other salts) and dilution (from 0.656 . 10m3 M to 
0.00656 . 1O-3 M, i.e. 0.1 to 0.001 mg/ml) had only a very 
small effect on the helical integrity of (P,)n. The ellipticity 
could be only slightly lowered by raising the temperature 
to 40°C. 
The polymer (P,,)n was also found to aggregate. Gel- 
permeation chromatography using G75 Sephadex 
showed that the major fraction of the polymer was eluted 
in the void volume corresponding to a molecular weight 
of 70,000 Da or more. Since the molecular weight deter- 
mined by viscometry in denaturating conditions (in TFA 
solution) was 12,120 only (Table l), this corresponds 
approximately to a 6-mer aggregate. The aggregation 
contributes probably to the high helical stability of (P&z. 
The (P,)3 oligomer also showed the typical CD fea- 
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Fig. 2. Proliferative responses of polyoctapeptide-primed lymph node cells from various strains of mice. Balblc, C57B116 and C3H/j mice were 
immunized with 50 pg of (P&t (A), (P&t (B), and (P&r (C). IO days later, their lymph node cells were stimulated in vitro with the homologous 
polyoctdpeptide. (D) Proliferative responses of lymph node cells of Balbk mice to 40 pg/ml homologous polyoctapeptides (P&r, (P,)n and (P&r. 
tures (not shown here) of an a-helix, although, as ex- 
pected for a rather short peptide, ellipticities were lower 
(0 222 nm = -12,000) than for the corresponding polymer. 
(P,)3 is also aggregated as shown by osmometric meas- 
urements. The average molecular weight in 0.1 M NaF 
thus estimated corresponded to a 5-mer aggregate, con- 
sistent with the value found for the polymer. 
CD spectrum of (P,)n indicates a completely unor- 
dered conformation, with a trough at 198 nm, while the 
CD spectrum of (P&r with one proline per repeat unit 
only reflects a partly a-helical structuration which in- 
creases slightly when pH is raised from 3 to 7. Neither 
of the polymers aggregate as found by gel-permeation 
chromatography and osmometric measurements. 
3.3. T-cell proliferative responses 
The re-stimulation of T-cell proliferation by (P&r, 
(P,)n and (P2)n was systematically assayed on H2b 
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Fig. 3. (P&-specific proliferation of CD4’ T-lymphocytes. Balbk mice 
were immunized with 50 pg of (P&r. 10 days later, the proliferative 
responses of their lymph node cells to (P&I (40 pg/ml) were assayed in 
the presence of anti-CD4 or anti-CD8 monoclonal antibodies. 
(C57B1/6 mice), H2d (Balb/c mice) and H2k (C3H mice) 
restricted T-cells. For each polyoctapeptide, two groups 
of mice were immunized with either polyoctapeptide or 
0.9% NaCl only, as control, to detect possible non-spe- 
cific proliferation. None of these polyoctapeptides i  mi- 
togenic (data not shown). Balb/c mice show the best 
response after immunization with polypeptides (Fig. 2). 
Therefore, comparisons between T-cell activities were 
carried out using this strain only. Fig. 3 shows that the 
(P&-specific proliferation of lymph node cells from 
(P&-primed Balb/c mice was totally inhibited by the 
addition to the culture of anti-CD4’ monoclonal anti- 
bodies but was not affected by co-culture with anti-CDS’ 
monoclonal antibodies even at high doses. Very similar 
results were obtained with (P&I as antigen. Thus, the 
specific proliferative response observed is due to the 
stimulation of the CD4’ T-cell subset only. 
The polyoctapeptide (P&I induces excessive T-cell 
proliferation, while (PJn (one proline every eight resi- 
dues) induces a significant but less-pronounced one than 
that of the polymer with two prolines (Fig. 2). On (P&z- 
primed T-cells, the proliferation induced by (P&I was of 
the same order of magnitude as that induced by (P&z, 
whereas on (P&r-primed T-cell, (P&I was twofold less 
active than (P&r (Fig. 4). 
The polymer (P&I (without proline), in the a-helical 
conformation (f!& nm = -30,000) is inactive (Fig. 2), 
whereas the oligomer (P,)3, which is also helical but to 
a lesser extent (eZZZnrn = - 12,000) is able to re-stimulate 
T-cell proliferation when mice received 100 ,ug antigen 
(Fig. 5). At high concentrations, (PJ3 is cytotoxic, prob- 
ably due to its amphipathic haracter [17]. 
4. Discussion 
Our experiments 
of macromolecular 
aimed to study if the conformation 
polypeptides formed by tandem re- 
peats of octapeptides could influence the generation of 
T-cell epitopes. Some studies regarding the conforma- 
tion of T-cell epitopes by CD spectroscopy have been 
reported [18,19]. These studies were carried out with 
short peptides which usually do not adopt a well-defined 
conformation in water, and are forced into a more stable 
structure, generally a-helical, by adding trifluoroetha- 
nol. Macromolecules like sequential polypeptides of lim- 
ited amino acid diversity, but of different amino acid 
sequences, offer a valuable system to obtain stable con- 
formations in water. (P&r shows a particularly stable 
a-helical conformation, stabilized probably by an aggre- 
gation phenomenon which was evidenced by gel-chrom- 
atography. Starting from a stable a-helical amphipathic 
polyoctapeptide (P&r, it was found, as expected, that 
progressive substitution of Leu by Pro gradually desta- 
bilizes the initial a-helix. The presence of two prolines 
per repeat unit in (P&I impedes the formation of the 
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Fig. 4. Proliferative responses to heterologous polyoctapeptide. Balbk 
mice were immunized with 50 pg of (P,)n (A) and (P&I (B). 10 days 
later, lymph node cells were stimulated in vitro with 40 pg/rnl of (P,)n 
(cross-hatched bars), (P&I (filled bars) and (P8R)n (open bars), an 
irrelevant polyoctapeptide (KGNPREEE)n. 
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[21,22] protects them from proteolytic degradation. In 
the case of amphipathic and helical PO-based peptides, 
aggregation contributes probably to enhance their stabil- 
ity against proteolytic processing, thus rendering this 
macromolecule silent for the immune system. 
The results herein reported illustrate the usefulness of 
the structural approach. Our observations suggest that 
conformation and aggregation must be taken into ac- 
count in the study of antigen processing and presenta- 
tion. Furthermore, a silent macromolecule for the im- 
mune system, like (P&z, would be of interest as a carrier 
of epitopes by increasing their life-time. 
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a-helix, while (Pl)n, with one proline only, gives rise to 
a partly helical structure. 
In vitro proliferation of T-cells with this series of pol- 
ypeptides shows that polypeptides containing proline 
give rise to T-cell proliferation, while a proline-free pol- 
ypeptide of very close sequence is inactive. The magni- 
tude of the proliferative response obtained with the most 
active polymers is of the same order as for a natural 
protein such as ovalbumin [20]. The behavior of (P,)n is 
comparable to that of (P&z. Indeed, (P&t induces a 
T-cell response that can be recalled by (P&r within the 
same order of magnitude, while (PJn recalls the T-cell 
response induced by (P&r but to a lesser extent. The 
substitution of Leu bv Pro modifies the conformation of 
the polyoctapeptide but also introduces a new side chain 
which might interact more favorably with the MHC mol- 
ecules. 
In the case of (P&z, several reasons can be put forward 
to explain the lack of T-cell response: (i) a deficiency in 
expressing T-cell receptors able to recognize the proc- 
essed peptides; (ii) inability of MHC molecules to bind 
to the processed peptides and thus to present them to the 
T-cell receptors; (iii) the processing of the native peptide 
does not take place and consequently no peptides able 
to bind to MHC molecules are generated. Since the oli- 
gomer (P,)3, which has the same sequence as (P& but 
with 3 repeat units only, re-stimulates the proliferation 
of T-cells, hypotheses (i) and (ii) can be ruled out so that 
the last one seems the more plausible. It is well-known 
that unordered conformations are more sensitive to pro- 
teolysis than helical and aggregated structures. For ex- 
ample, it has been reported that the amphipathic helical 
structure of two peptides analogous to /?-endorphin 
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